Equaly
Pre-clinicalEqualy’s technology platform modulates immune responses based on antigen-specific cells of the innate immune system. This opens the door to better biologicals and new immunotherapies for cancer, infectious diseases and auto-immune diseases.
Founded
2019
Focus
Digital Health
About
Equaly’s technology platform modulates immune responses based on antigen-specific cells of the innate immune system. This opens the door to better biologicals and new immunotherapies for cancer, infectious diseases and auto-immune diseases.
Company Info
TypePrivate
Founded2019
LocationLeuven, Belgium
StagePre-clinical
Contact
SIMILAR COMPANIES
Miracor Medical
Pre-clinical · Zaventem
AML Clinical Services
Pre-clinical · Leuven
Anacura
Pre-clinical · Ghent
Aseptic Technologies
Pre-clinical · Gembloux
Aspect Analytics
Pre-clinical · Leuven
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile